These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
895 related articles for article (PubMed ID: 25992654)
1. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma. Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway. Xia Y; He Z; Liu B; Wang P; Chen Y Mol Med Rep; 2015 Sep; 12(3):4530-4537. PubMed ID: 26059239 [TBL] [Abstract][Full Text] [Related]
3. LncRNA XIST promotes human lung adenocarcinoma cells to cisplatin resistance via let-7i/BAG-1 axis. Sun J; Pan LM; Chen LB; Wang Y Cell Cycle; 2017; 16(21):2100-2107. PubMed ID: 28961027 [TBL] [Abstract][Full Text] [Related]
4. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression. Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741 [TBL] [Abstract][Full Text] [Related]
5. Long non‑coding RNA AK001796 contributes to cisplatin resistance of non‑small cell lung cancer. Liu B; Pan CF; Ma T; Wang J; Yao GL; Wei K; Chen YJ Mol Med Rep; 2017 Oct; 16(4):4107-4112. PubMed ID: 29067469 [TBL] [Abstract][Full Text] [Related]
6. The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21(WAF1/CIP1) expression. Liu Z; Sun M; Lu K; Liu J; Zhang M; Wu W; De W; Wang Z; Wang R PLoS One; 2013; 8(10):e77293. PubMed ID: 24155936 [TBL] [Abstract][Full Text] [Related]
7. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner. Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681 [TBL] [Abstract][Full Text] [Related]
8. GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin. Gong X; Liu J; Zhang D; Yang D; Min Z; Wen X; Wang G; Li H; Song Y; Bai C; Li J; Zhou J PLoS One; 2017; 12(8):e0182410. PubMed ID: 28771580 [TBL] [Abstract][Full Text] [Related]
9. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET. Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910 [TBL] [Abstract][Full Text] [Related]
10. Aberrant Long Noncoding RNAs Expression Profiles Affect Cisplatin Resistance in Lung Adenocarcinoma. Hu L; Chen J; Zhang F; Wang J; Pan J; Chen J; Wang Y Biomed Res Int; 2017; 2017():7498151. PubMed ID: 29279851 [TBL] [Abstract][Full Text] [Related]
11. sCLU regulates cisplatin chemosensitivity of lung cancer cells in vivo. Ma G; Cai H; Gao L; Wang M; Wang H World J Surg Oncol; 2015 Feb; 13():80. PubMed ID: 25884382 [TBL] [Abstract][Full Text] [Related]
12. siRNA silencing EZH2 reverses cisplatin-resistance of human non-small cell lung and gastric cancer cells. Zhou W; Wang J; Man WY; Zhang QW; Xu WG Asian Pac J Cancer Prev; 2015; 16(6):2425-30. PubMed ID: 25824776 [TBL] [Abstract][Full Text] [Related]
13. [Effects of bevacizumab and cisplatin on human lung adenocarcinoma A549/DDP xenografts in nude mice]. Dai M; Luo RC; Zheng DY; Lü CW; Ding XM Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1402-5. PubMed ID: 17884788 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA CCAT1 acts as an oncogene and promotes chemoresistance in docetaxel-resistant lung adenocarcinoma cells. Chen J; Zhang K; Song H; Wang R; Chu X; Chen L Oncotarget; 2016 Sep; 7(38):62474-62489. PubMed ID: 27566568 [TBL] [Abstract][Full Text] [Related]
15. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway. Shi H; Pu J; Zhou XL; Ning YY; Bai C Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375 [TBL] [Abstract][Full Text] [Related]
16. Reversal of galectin-1 gene silencing on resistance to cisplatin in human lung adenocarcinoma A549 cells. Zhang L; Liu X; Tang Z; Li X; Wang G Biomed Pharmacother; 2016 Oct; 83():265-270. PubMed ID: 27392028 [TBL] [Abstract][Full Text] [Related]
17. LncRNA RP3-326I13.1 promotes cisplatin resistance in lung adenocarcinoma by binding to HSP90B and upregulating MMP13. Zhou H; Huang X; Shi W; Xu S; Chen J; Huang K; Wang Y Cell Cycle; 2022 Jul; 21(13):1391-1405. PubMed ID: 35298351 [TBL] [Abstract][Full Text] [Related]
18. miR-326 reverses chemoresistance in human lung adenocarcinoma cells by targeting specificity protein 1. Li J; Li S; Chen Z; Wang J; Chen Y; Xu Z; Jin M; Yu W Tumour Biol; 2016 Oct; 37(10):13287-13294. PubMed ID: 27460077 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway. Pan Y; Chen J; Tao L; Zhang K; Wang R; Chu X; Chen L Oncotarget; 2017 May; 8(20):33144-33158. PubMed ID: 28388536 [TBL] [Abstract][Full Text] [Related]
20. Downregulated long non-coding RNA TRPM2-AS inhibits cisplatin resistance of non-small cell lung cancer cells via activation of p53- p66shc pathway. Ma LY; Xie XW; Ma L; Pang JL; Xiong XM; Zheng HD; Shen XL; Wen ZG; Wang HY Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2626-2634. PubMed ID: 28678322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]